MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin

AGONISTS that stimulate protein kinase C (PKC) induce profound changes in cell morphology correlating with the reorganization of submembranous actin, but no direct connection between PKC and actin assembly has been identified. The myristoylated, alanine-rich C kinase substrate (MARCKS) binds calmodu...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 356; no. 6370; pp. 618 - 622
Main Authors Hartwig, J. H, Thelen, M, Resen, A, Janmey, P. A, Nairn, A. C, Aderem, A
Format Journal Article
LanguageEnglish
Published London Nature Publishing 16.04.1992
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AGONISTS that stimulate protein kinase C (PKC) induce profound changes in cell morphology correlating with the reorganization of submembranous actin, but no direct connection between PKC and actin assembly has been identified. The myristoylated, alanine-rich C kinase substrate (MARCKS) binds calmodulin and is a predominant, specific substrate of PKC which is phosphorylated during macrophage and neutrophil activation , growth factor-dependent mitogenesis and neurosecretion; it is redistributed from plasma membrane to cytoplasm when phosphorylated and is involved in leukocyte motility. Here we report that MARCKS is a filamentous (F) actin crosslinking protein, with activity that is inhibited by PKC-mediated phosphorylation and by binding to calcium-calmodulin. MARCKS may be a regulated crossbridge between actin and the plasma membrane, and modulation of the actin crosslinking activity of the MARCKS protein by calmodulin and phosphorylation represents a potential convergence of the calcium-calmodulin and PKC signal transduction pathways in the regulation of the actin cytoskeleton.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0028-0836
1476-4687
DOI:10.1038/356618a0